Statutory Instrument 1994 No. 899

      The Medicines (Homoeopathic Medicinal Products for Human Use) Amendment Regulations 1994


      © Crown Copyright 1994

      Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament.

      The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users.

      It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document.

      The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the The Medicines (Homoeopathic Medicinal Products for Human Use) Amendment Regulations 1994, ISBN 011043899X. The print version may be purchased by clicking here. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail:customer.services@tso.co.uk.

      Further information about the publication of legislation on this website can be found by referring to the Frequently Asked Questions.

      To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.

 

This Statutory Instrument has been made in consequence of errors in S.I. 1994/105 and is being issued free of charge to all known recipients of that Statutory Instrument.


STATUTORY INSTRUMENTS

1994 No. 899

MEDICINES

The Medicines (Homoeopathic Medicinal Products for Human Use) Amendment Regulations 1994

Made 24th March 1994
Laid before Parliament 30th March 1994
Coming into force 20th April 1994

    The Secretary of State, in exercise of the powers conferred upon her by section 2(2) of the European Communities Act 1972[1], being designated for the purposes of that section in relation to medicinal products[2], hereby makes the following Regulations:
    Citation, commencement and interpretation
        1.—(1)  These Regulations may be cited as the Medicines (Homoeopathic Medicinal Products for Human Use) Amendment Regulations 1994 and shall come into force on 20th April 1994.

        (2)  In these Regulations, "the principal Regulations" means the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994[3].
    Amendment of regulation 5 of the principal Regulations
        2.—(1)  Regulation 5 of the principal Regulations (determination of application for certificate) shall be amended in accordance with the following paragraphs.

        (2)  In paragraph (2), for "paragraph (3)" there shall be substituted "paragraph (4)".

        (3)  For paragraph (3), there shall be substituted the following paragraph—
      "  (3)  A product shall not be considered to have a sufficient degree of dilution to guarantee its safety if—
        (a) in the case of a product containing an active principle whose presence in an allopathic medicinal product would require it to be sold by retail or supplied in circumstances corresponding to retail sale in accordance with a prescription given by a doctor, it contains either more than one part per 10,000 of the mother tincture or more than one hundredth of the smallest dose of that active principle used in allopathy, or
        (b) in any other case, it contains more than one part per 10,000 of the mother tincture." .

    Amendment of regulation 9 of the principal Regulations
        3.    For paragraph (2) of regulation 9 of the principal Regulations (suspension and revocation) there shall be substituted the following paragraph—
      "  (2)  Before suspending or revoking a certificate of registration on a ground set out in paragraph (1)(a) or (b) above, the licensing authority shall consult the Board, except in a case to which paragraph 11 of Schedule 2 to the Act, as applied by these Regulations, applies (procedure in the case of urgency)." .
    Amendment of Schedule 4 to the principal Regulations
        4.—(1)  Schedule 4 to the principal Regulations (application of provisions of the Act) shall be amended in accordance with the following paragraphs.

        (2)  In the modification to section 92 of the Medicines Act 1968[4], for "has though" there shall be substituted "as though".

        (3)  In the first modification to section 107 of that Act, for "1993" there shall be substituted "1994".

        (4)  For the first modification to Schedule 2 to that Act, there shall be substituted the following—
      "as though for "the licence"and "licence" (wherever those words appear) there were substituted "the certificate" and "certificate", respectively;" .


Signed by authority of the Secretary of State for Health

Tom Sackville

Parliamentary Under Secretary of State, Department of Health

24th March 1994






EXPLANATORY NOTE

(This note is not part of the Regulations)
    These Regulations amend the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994 ("the principal Regulations"), which came into force on 14 February 1994.
    Regulation 2(3) substitutes regulation 5(3) of the principal Regulations, in order to make it clearer. Regulation 5(3) sets out the criteria for determining whether a product is to be considered to have a sufficient degree of dilution to guarantee its safety: regulation 5(2) of the principal Regulations requires the licensing authority to refuse to grant a certificate of registration in respect of a homoeopathic medicinal product if the product does not have that sufficient degree of dilution.
    Regulation 3 substitutes regulation 9(2) of the principal Regulations to require the licensing authority to consult the Advisory Board on the Registration of Homoeopathic Products before revocation, as well as before nsion, of a certificate of registration (except in cases of emergency). Regulations 2(2) and 4 make drafting amendments.



ISBN 0 11 043899 X




Notes:

[1] 1972 c. 68. back

[2] S.I. 1972/1811. back

[3] S.I. 1994/105. back

[4] 1968 c. 67. back

 

Other UK SIs | Home | National Assembly for Wales Statutory Instruments | Scottish Statutory Instruments | Statutory Rules of Northern Ireland | Her Majesty's Stationery Office

We welcome your comments on this site
© Crown copyright 1994
Prepared 20th September 2000